Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

about

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

Item

http://www.wikidata.org/entity/Q42287336

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

@en

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

@nl

type

Item

label

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

@en

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

@nl

prefLabel

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

@en

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

@nl

P1476

Accomplishments in 2008 in the management of gastrointestinal stromal tumors.

@en

P2093

Charles Blanke

http://www.w3.org/2001/XMLSchema#string

Daniel Renouf

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

PDGFRA activating mutations in gastrointestinal stromal tumors.

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

P304

S67-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

5 Supplement 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Yves Blay

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20011569

http://www.w3.org/2001/XMLSchema#string

P932

2791388

http://www.w3.org/2001/XMLSchema#string